The Brown University Child and Adolescent Psychopharmacology Update This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Maternal depression study calls for more research into mother ‐child dyad, parenting interventions
Maternal depression study calls for screening (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - February 21, 2018 Category: Psychiatry Tags: Research Brief Source Type: research

CADCA tackles e ‐cigarettes, vaping, and nicotine
CADCA tackles e‐cigarettes, vaping, and nicotine (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - February 21, 2018 Category: Psychiatry Tags: News Source Type: research

SSRI use in late pregnancy increases risk of internalizing disorders in preschool offspring, no risk to development
Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) has no substantial increased risk on children's behavioral, emotional, and social development, according to a study that followed mother‐child dyads from pregnancy through age 5 of the child. There was a risk for great anxious/depressed behaviors in the children when the SSRI was taken during late pregnancy only, but unmeasured confounding can't be ruled out, the researchers concluded. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - February 21, 2018 Category: Psychiatry Tags: What's ‐New‐in‐Research Source Type: research

Teens presenting with late ‐onset ADHD symptoms and requesting stimulant medication: Next step?
When an adolescent or young adult seeks stimulant medication for late‐onset attention‐deficit/hyperactivity disorder (ADHD) symptoms, what kind of screening instruments can be used, and what are possible alternative causes of symptoms? Researchers examined psychiatric assessments and discovered that only 2.5% of the teens who screened positive in initial checklists actually had late‐onset ADHD. Some of those teens had undetected childhood ADHD. The main reason for impairing late‐onset ADHD symptoms that was not ADHD was substance use — in this study, marijuana use. (Source: The Brown University Child and Adolesce...
Source: The Brown University Child and Adolescent Psychopharmacology Update - February 21, 2018 Category: Psychiatry Tags: What's ‐New‐in‐Research Source Type: research

Prevalence of ADHD and predictors of stimulant and antipsychotic medications
The main predictor of a child with attention‐deficit/hyperactivity disorder (ADHD) being prescribed psychotropic medications in addition to stimulants is a psychiatric consultation, according to a new study from Canada. Researchers looked at children in Ontario to determine the predictors of medication prescription for ADHD in youth, as well as the prevalence and characteristics of youth with ADHD. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - February 21, 2018 Category: Psychiatry Tags: ADHD Source Type: research

RCT finds lurasidone improves bipolar I depression in children and adolescents
Lurasidone improves symptoms of bipolar depression in children and adolescents, researchers have found. The trial was randomized, double‐blind, and placebo‐controlled, and the study was published in the December 2017 issue of the Journal of the American Academy of Child and Adolescent Psychiatry. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - January 30, 2018 Category: Psychiatry Tags: Bipolar Disorder Source Type: research

Patient Information Sheet
(Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - January 30, 2018 Category: Psychiatry Tags: Supplement Source Type: research

FDA revises labeling to limit pediatric use of prescription cough and cold medicines
The U.S. Food and Drug Administration announced last month that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years old because the serious risks of these medicines outweigh their potential benefits in this population. After safety labeling changes are made, these products will no longer be indicated for use to treat cough in any pediatric population and will be labeled for use only in adults aged 18 years and older. Labeling for the medications also is being updated with additional safety information fo...
Source: The Brown University Child and Adolescent Psychopharmacology Update - January 30, 2018 Category: Psychiatry Tags: From the FDA Source Type: research

News
Tapering long‐term opioids: Do it gradually and with help from addiction medicine NAATP announces revised code of ethics, complaint process Abuse‐deterrent opioids may not save money or lives: Study Pregnant women who use drugs may lose custody (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - January 30, 2018 Category: Psychiatry Tags: News Source Type: research

Folic acid and multivitamins before and during pregnancy linked to lower risk of ASD in offspring
Researchers examined the associations between maternal folic acid and multivitamin supplements before and during pregnancy, and the risks of autism spectrum disorder (ASD) in their offspring. They found that maternal use of folic acid and/or multivitamin supplements before or during pregnancy was associated with a lower likelihood of ASD in offspring compared to mothers who had no folic acid or multivitamin supplements before or during pregnancy. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - January 30, 2018 Category: Psychiatry Tags: Whats ‐New‐in‐Research Source Type: research

Prematurity and low birth weight associated with increased risk of ADHD diagnosis and symptoms: Meta ‐analysis
Preterm and low‐birth‐weight (LBW) newborns have an increased risk of being diagnosed with attention‐deficit/hyperactivity disorder (ADHD) compared with controls, researchers have found in a literature review. These risks are even greater as preterm and low birth weight are more extreme. The researchers, whose study is published in the January issue of Pediatrics, found that very preterm/very low‐birth‐weight (VP/VLBW) subjects have an increased risk of ADHD diagnosis and symptomatology, and the findings are even stronger in the extremely preterm/extremely low‐birth‐weight (EP/ELBW) group. They recommend that...
Source: The Brown University Child and Adolescent Psychopharmacology Update - January 30, 2018 Category: Psychiatry Tags: ADHD Source Type: research

Physicians present case for legalizing marijuana
Three eminent physicians present a compelling case for legalizing marijuana in the November issue of the American Journal of Public Health. The opinion piece, “The Physicians' Case for Marijuana Legalization,” written by David L. Nathan, M.D.; H. Westley Clark, M.D., J.D.; and Joycelyn Elders, M.D., states that it's time for federal law to change and make marijuana legal, as it is for medical purposes in 29 states and for any purpose, including recreational, in eight states. More than 60 percent of Americans favor legalization. And most important, marijuana prohibition “has done more damage to public health than has ...
Source: The Brown University Child and Adolescent Psychopharmacology Update - December 26, 2017 Category: Psychiatry Tags: Substance Use Source Type: research

FDA approves new indication — opioid withdrawal — for electric stimulation device
In November, the U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - December 26, 2017 Category: Psychiatry Tags: From the FDA Source Type: research

Research Roundup
Legalization brings high‐potency cannabis to market, with higher prices consumers are willing to pay Stigma of medications may hinder treatment of opioid use disorders in adolescents Atomoxetine ‘sleep neutral’ in children with ASD or ADHD Vaping and marijuana top concerns in high school survey (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - December 26, 2017 Category: Psychiatry Tags: Research Roundup Source Type: research

Focus on irritability and callous traits in early identification of disruptive behavior
Childhood disruptive behavior should no longer be viewed along the oppositional defiant/conduct disorder/antisocial behavior continuum, but rather as heterogeneous phenotypes with irritability and callous traits as the core dimensions, researchers write. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - December 26, 2017 Category: Psychiatry Tags: What's New in Research Source Type: research